While CD133 is often expressed in specific histological tumor types and is associated with higher tumor levels, the expression of CD44 is not related to tumor histology or tumor grading, making CD133 more clinically relevant than CD44 (28, 29). The gene discussed is CD44; the disease is neoplasm.